Adebayo G I, Mabadeje A F
Department of Pharmacology, College of Medicine, Lagos, Nigeria.
Biopharm Drug Dispos. 1990 Mar;11(2):157-64. doi: 10.1002/bdd.2510110208.
On the basis of reports that some calcium channel blockers impair the elimination of some drugs, the effect of nifedipine on the disposition of antipyrine and theophylline was assessed in healthy volunteers. Antipyrine half-life of 10.04 +/- 1.43 h (mean +/- SD) after a week intake of nifedipine (20 mg twice daily) was not significantly different from the control value of 10.64 +/- 2.15 h; nor was that of 10.02 +/- 1.49 h after 2 weeks pretreatment with the calcium channel blocker in eight healthy volunteers. Control antipyrine clearance (ml min-1) of 44.40 +/- 10.58 was not significantly different from that of 45.66 +/- 9.34 and 46.87 +/- 9.63 after nifedipine pretreatment of 1 and 2 weeks, respectively. Similarly volume of distribution was unaltered: 0.601 +/- 0.074, 0.591 +/- 0.078 and 0.602 +/- 0.051 l kg-1, respectively. A week pretreatment with nifedipine did not significantly alter either of theophylline half-life (7.32 +/- 0.81 h (control) to 7.50 +/- 0.80 h) or clearance (42.10 +/- 5.84 ml min-1 (control) to 43.77 +/- 4.00 ml min-1) in six volunteers. However the change in volume of distribution: 0.451 +/- 0.053 l kg-1 (control) to 0.483 +/- 0.062 l kg-1 was significant (p less than 0.025). Generally, theophylline plasma levels were lower after nifedipine pretreatment and the difference was significant at 2 and 4 h post-dosing (p less than 0.05). It is suggested that nifedipine, unlike diltiazem and verapamil, is unlikely to interfere with the functional integrity of the hepatic mixed-function oxygenase enzymes, but might displace theophylline from plasma protein.
基于一些钙通道阻滞剂会影响某些药物消除的报道,在健康志愿者中评估了硝苯地平对安替比林和茶碱处置的影响。在一周内每日两次服用硝苯地平(20毫克)后,安替比林的半衰期为10.04±1.43小时(平均值±标准差),与对照值10.64±2.15小时无显著差异;在八名健康志愿者中,用钙通道阻滞剂预处理2周后,安替比林半衰期为10.02±1.49小时,也无显著差异。对照时安替比林清除率(毫升/分钟)为44.40±10.58,与硝苯地平预处理1周和2周后的清除率45.66±9.34及46.87±9.63无显著差异。同样,分布容积也未改变,分别为0.601±0.074、0.591±0.078和0.602±0.051升/千克。在六名志愿者中,用硝苯地平预处理一周对茶碱半衰期(从对照时的7.32±0.81小时变为7.50±0.80小时)或清除率(从对照时的42.10±5.84毫升/分钟变为43.77±4.00毫升/分钟)均无显著影响。然而,分布容积的变化(从对照时的0.451±0.053升/千克变为0.483±0.062升/千克)具有显著性(p<0.025)。一般来说,硝苯地平预处理后茶碱的血浆水平较低,且在给药后2小时和4小时差异具有显著性(p<0.05)。提示与地尔硫䓬和维拉帕米不同,硝苯地平不太可能干扰肝脏混合功能氧化酶的功能完整性,但可能会使茶碱从血浆蛋白中置换出来。